The American Society of Nephrology (ASN) has announced that Michelle A. Josephson will become the society’s next president. Josephson, who succeeds Susan E. Quaggin, will assume her new role on 1 January 2023.
A highly experienced physician and academic leader, Josephson is currently a professor of Medicine and Surgery at the University of Chicago (Chicago, USA), medical director of the University of Chicago Kidney and Pancreas Transplant Program, and programme director of the Transplant Nephrology Fellowship.
Josephson is deeply committed to research, education, and care in the realm of kidney transplantation, with particular interests in living kidney donation, post-transplant bone disease, BK virus, and pregnancy in transplant recipients. Having authored more than 100 articles and five book chapters, and having presented numerous invited lectures nationally and internationally, Josephson has helped to shape the field of nephrology—from clinical research to clinical care, to education for the next generation of nephrologists.
Josephson currently serves on the ASN Council as president-elect. She has served as chair of the Transplant Advisory Group, the Policy and Advocacy Committee, and the ASN Early Program on Kidney Transplantation. She has also been a member of numerous ASN committees and groups, including the ASN COVID response team. Josephson chaired the American Society of Transplantation (AST) Cutting Edge of Transplantation 2020 and 2021 meetings, and the Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference on the Failing Allograft. From 2007 to 2010, she served as a Councilor-at-Large on the AST Board of Directors. From 2005 to 2006, she was president of Women in Nephrology. She serves on the editorial board of the Clinical Journal of the American Society of Nephrology (CJASN) and was an associate editor for Transplantation.